| Active substance | Sodium thiosulfate |
| Holder | Norgine nv/sa |
| Status | Running |
| Indication | Prevention of ototoxicity induced by cisplatin (CIS) chemotherapy in patients 1 month to < 18 years of age with localized, non-metastatic, solid tumors. |
| Public documents | Approbation |
| Information for the patient | |
| Informed consent - 7-11 year | |
| Informed consent - 12-17 year | |
| Informed consent - adult | |
| Last update | 14/08/2025 |